Anti-Inflammatory Therapeutics Market qualitative insights on application and outlook by size, share and future growth
The anti-inflammatory therapeutics market is expected to grow at the highest CAGR of 13.9% during the forecast period.
PORTLAND, OREGON, USA, July 13, 2022 /EINPresswire.com/ — Asia-Pacific Anti-Inflammation Therapies Market Research Report 2014-2020, Asia-Pacific Anti-Inflammation Therapies Market is expected to grow at a CAGR of 8.6% over the period 2015-2020. The arthritis segment would continue to dominate the anti-inflammatory therapies market in Asia-Pacific through 2020. The Chinese anti-inflammatory therapies market is expected to grow at the highest CAGR of 13.9% during the period forecast.
𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:
Major companies operating in the market are Pfizer Inc., AbbVie Inc., Johnson & Johnson, GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, F. Hoffmann-La Roche AG, Eli Lily and Company, AstraZeneca PLC and Amgen Inc.
𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘
• China is expected to overtake Japan by 2018 in the anti-inflammatory therapy market in Asia-Pacific
• India’s anti-inflammatory therapy market is expected to account for around 13% of the Asia-Pacific market by 2020
• China and India would rule about half of the NSAID market in Asia-Pacific by 2020
• Japan accounted for about 1/3 of the anti-inflammatory biologics market in 2014, the highest of all
• Arthritis indication was the largest revenue-generating segment in the APAC anti-inflammatory indication market in 2014
• Psoriasis indication expected to grow at a CAGR of 10.7%, the fastest among all indications
Inflammation is a nonspecific immune defense mechanism of the body triggered by injuries, bacterial or viral infections, or any damage to internal or external organs. When this inflammation persists longer, it can lead to chronic diseases such as atherosclerosis and rheumatoid arthritis, to name a few. Currently, reducing inflammation, especially in chronic diseases, is the widely accepted therapeutic approach taken by physicians.
Rising incidence of autoimmune and respiratory diseases, increasing R&D investments in China and India, and large amount of biosimilar drugs under development would drive the growth of anti-inflammatory therapies market in Asia Pacific. In addition, factors such as the existence of established markets for NSAIDs and corticosteroids, mass adoption of over-the-counter (OTC) NSAIDs, such as ibuprofen and naproxen, in China and India and government initiatives in the Asia-Pacific region would further drive the market growth. . However, adverse effects associated with prolonged consumption of drugs such as NSAIDs and corticosteroids and issues of uncertain patent legislations such as compulsory licensing in India would limit the market growth. High price sensitivity in countries like India and China would be the main challenge for drug innovators to get their patented drugs to market.
The anti-inflammatory biologics segment dominated the market in 2014 and is expected to exhibit the highest growth rate over the forecast period. This is due to the unparalleled benefits offered by biologic drugs and their rapid adoption in countries like Japan, as well as improved access to healthcare and increased healthcare expenditure. The popularity of corticosteroids has declined due to withdrawal symptoms and toxicity issues.
𝐖𝐞 𝐚𝐥𝐬𝐨 𝐎𝐟𝐟𝐞𝐫𝐬 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐮𝐧𝐭𝐫𝐲 𝐑𝐞𝐩𝐨𝐫𝐭𝐬-
North America Anti-Inflammatory Therapeutics Market
Japanese Anti-Inflammatory Therapies Market
Anti-Inflammatory Therapies Market in South Korea
Singapore Anti-Inflammatory Therapies Market
Australian anti-inflammatory therapeutics market
European anti-inflammatory therapeutics market
𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬
Intravenous (IV) Therapy and Venous Access Market
IVD market in Germany
𝐀𝐛𝐨𝐮𝐭 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 :
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global corporations as well as small and medium enterprises with unrivaled quality of “market research reports” and “Business Intelligence solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market areas. AMR offers its services in 11 industry sectors, including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverage, Energy & Power, semiconductors and electronics, automotive and transport, ICT and media, aerospace and defense and BFSI.
We maintain professional relationships with various companies which helps us to extract market data which helps us to generate accurate research data tables and confirm the utmost accuracy of our market predictions. Allied Market Research CEO Pawan Kumar helps inspire and encourage everyone associated with the company to maintain high quality data and help clients in every way possible to achieve success. All data presented in the reports we publish are drawn from primary interviews with senior executives from leading companies in the relevant field. Our secondary data sourcing methodology includes extensive online and offline research and discussions with knowledgeable industry professionals and analysts.
Allied Analytics LLP
write to us here
Visit us on social media: